Modified GRF (1-29) Peptide 2mg Vial – GHRH Research Peptide

What Is Modified GRF (1-29)?

Modified GRF (1-29), also known as a refined GHRH analog, is a synthetic peptide widely used in growth hormone research. Designed for improved stability, it mimics natural growth hormone-releasing hormone while offering more consistent performance in laboratory settings.

CAS登録番号	863288-34-0
その他の名称	Modified GRF (1-29), Tetrasubstituted GRF (1-29),
IUPAC名	該当なし
分子式	C₁₅₂H₂₅₂N₄₄O₄₂
分子量	3367.95
純度	≥99% 純度（LC-MS）
流動性の可用性	該当なし
粉末の在庫状況	2 milligrams (lyophilized/freeze-dried)
保管条件	要冷蔵。冷凍保存はしないでください。.
利用規約	すべての製品は実験室における開発研究用のみを目的としており、人への使用は禁じられています。.

---

仕組み

Growth Hormone Signaling Support

This peptide binds to GHRH receptors in the pituitary gland, helping researchers study pulsatile growth hormone release—a key factor in understanding endocrine balance and metabolic processes.

---

Why Choose a 2mg Vial?

Precision & Flexibility

The 2mg lyophilized format allows:

• Accurate measurement

• Controlled dosing in experiments

• Reliable storage and handling

Researchers often value its predictable response and stability, making it a dependable tool in peptide studies.

---

Storage Guidelines

• Store in a cool, dry place

• Refrigerate at 2–8°C after reconstitution

• Avoid repeated freeze–thaw cycles

---

よくある質問

What is Modified GRF (1-29) used for?

It is used in research involving growth hormone release and endocrine signaling.

How is it different from CJC-1295 with DAC?

It has a shorter action, allowing more natural hormone release patterns.

Is it for human use?

No, it is strictly for laboratory research purposes only.